Office of the Director Notice of Charter Renewal, 36078 [2014-14737]

Download as PDF 36078 Federal Register / Vol. 79, No. 122 / Wednesday, June 25, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Non-Competitive Program Expansion Supplement for Ryan White HIV/AIDS Part D Program, for Coordinated HIV Services and Access for Women, Infants, Children and Youth Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice of a Non-Competitive Program Expansion Supplement to the Ryan White HIV/AIDS Part D Program for Coordinated HIV Services and Access for Women, Infants, Children and Youth. AGENCY: The Health Resources and Services Administration (HRSA) will issue a non-competitive program expansion supplement to up to 115 Ryan White HIV/AIDS Part D program grantees to support interventions that will positively impact the HIV health outcomes of women, infants, children, and youth in communities where Part D grantees are located. HRSA will provide such one-time program expansion supplemental awards for Part D grantees, in an amount not to exceed the lesser of $150,000 or 25 percent of each fiscal year (FY) 2014 grant award. SUPPLEMENTARY INFORMATION: No additional information. SUMMARY: mstockstill on DSK4VPTVN1PROD with NOTICES Authority: Section 2671 of the Public Health Service (PHS) Act (42 U.S.C. 300ff– 71). CFDA Number: 93.918. Project period: The period of support for this award is 11 months. The project period is from August 1, 2014, through June 30, 2015. This is explained below in further detail. Justification for the Exception to Competition: The programmatic supplements will support the women, infants, children, and youth (WICY) populations served by Part D grantees and are designed to support interventions that will positively impact the HIV health outcomes in Part D grantee communities. The Part D Program Expansion Supplements will fund HIV Care Continuum interventions: (1) To enhance the competencies and skills of the HIV workforce (including health educators, linkage/retention staff, nurses, case managers/care coordinators, etc.) located at the Part D grantee site and partner sites to assist people living with HIV/AIDS (PLWH) in engagement and retention in HIV care; and (2) in medication adherence to achieve viral VerDate Mar<15>2010 18:01 Jun 24, 2014 Jkt 232001 load suppression. The numbers of PLWH to be impacted include more than 200,000 women, infants, children, and youth that are served by current Part D grantees. All currently funded Part D grantees (115) are eligible for this supplemental funding opportunity and the maximum cumulative total awards will not exceed $12,177,374. To conform to HRSA’s efforts to align project/budget period start dates with the standard quarterly dates, in the FY 2012 re-competition of the entire Part D program, the project period end date was established as June 30, 2015. As a result, the FY 2014 budget period for the Part D program grantees will be 11 months from August 1, 2014, through June 30, 2015. John Fanning, Senior Policy Advisor, Division of Community HIV/AIDS Programs, HAB, HRSA, 5600 Fishers Lane, Rockville, MD 20857, by email jfanning@hrsa.gov, or by phone at (301) 443–8367. FOR FURTHER INFORMATION CONTACT: Dated: June 16, 2014. Mary K. Wakefield, Administrator. [FR Doc. 2014–14873 Filed 6–24–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director Notice of Charter Renewal In accordance with Title 41 of the U.S. Code of Federal Regulations, Section 102–3.65(a), notice is hereby given that the Charter for the NIH ADVISORY BOARD FOR CLINICAL RESEARCH (ABCR) was renewed for an additional two-year period on April 26, 2014. It is determined that the ABCR is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquires may be directed to Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail Code 4875), Telephone (301) 496– 2123, or spaethj@od.nih.gov. PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 Dated: June 19, 2014. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–14737 Filed 6–24–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Notice of Charter Renewal In accordance with Title 41 of the U.S. Code of Federal Regulations, Section 102–3.65(a), notice is hereby given that the Charter for the National Cancer Institute Clinical Trials and Translational Research Advisory Committee was renewed for an additional two-year period on April 14, 2014. It is determined that the National Cancer Institute Clinical Trials and Translational Research Advisory Committee is in the public interest in connection with the performance of duties imposed on the National Cancer Institute and National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail code 4875), Telephone (301) 496– 2123, or spaethj@od.nih.gov. Dated: June 19, 2014. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–14739 Filed 6–24–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Health Assessment and Translation Webinar on Lessons Learned in Application of the OHAT Framework for Systematic Review and Evidence Integration to Case Studies; Notice of Public Webinar and Registration Information The National Toxicology Program (NTP) announces a public webinar, ‘‘Lessons Learned in Application of the Office of Health Assessment and Translation (OHAT) Framework for Systematic Review and SUMMARY: E:\FR\FM\25JNN1.SGM 25JNN1

Agencies

[Federal Register Volume 79, Number 122 (Wednesday, June 25, 2014)]
[Notices]
[Page 36078]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14737]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director Notice of Charter Renewal

    In accordance with Title 41 of the U.S. Code of Federal 
Regulations, Section 102-3.65(a), notice is hereby given that the 
Charter for the NIH ADVISORY BOARD FOR CLINICAL RESEARCH (ABCR) was 
renewed for an additional two-year period on April 26, 2014.
    It is determined that the ABCR is in the public interest in 
connection with the performance of duties imposed on the National 
Institutes of Health by law, and that these duties can best be 
performed through the advice and counsel of this group.
    Inquires may be directed to Jennifer Spaeth, Director, Office of 
Federal Advisory Committee Policy, Office of the Director, National 
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, 
Maryland 20892 (Mail Code 4875), Telephone (301) 496-2123, or 
spaethj@od.nih.gov.

    Dated: June 19, 2014.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-14737 Filed 6-24-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.